Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Gilead Sciences
Biotech
Topics

Advertisement

Advertisement

Gilead Sciences

Share

Top Latest Popular

Friday

Texas Continues to Target Pharma Patient Support Programs Under the Texas Anti-Kickback Statute JD Supra 21:29 Fri, 06 Nov

New Data Show Twice-Yearly Lenacapavir Achieved Nearly Twice the One-Year Persistence of Daily Oral F/Tdf in HIV Prevention Business Wire (Press Release) 17:19 Fri, 06 Nov

Gilead seeks wider use for Livdelzi on Phase III liver disease success Clinical Trials Arena 16:05 Fri, 06 Nov

Advertisement

Advertisement

Thursday

Gilead's Livdelzi Achieves 75% ALP Normalization In Phase 3 ideal Study; Stock Down RTT News 18:37 Thu, 05 Nov

AASLD 2026: Gilead Eyes Wider Livdelzi Use As Phase III Data Bolster PBC Expansion Plans Scrip Pharma Intelligence 15:54 Thu, 05 Nov

Gilead Sciences Has Raised Its Dividend for 11 Straight Years. Here's Why the Streak Looks Safe. The Motley Fool 11:00 Thu, 05 Nov

Wednesday

Stocks Surged Across the Board Today, and Biotech Brought Its Own Earnings Story PR Newswire (Press Release) 21:09 Wed, 04 Nov

FDA approval of generic lenacapavir will not guarantee access Doctors Without Borders (Press Release) 15:49 Wed, 04 Nov

Gilead and Kite Advance Leadership With New Data Across Pipeline and Portfolio at ash 2026 Business Wire (Press Release) 14:24 Wed, 04 Nov

Dr. Reddy's Generic HIV Prevention Shot Wins Tentative FDA Approval at $40 a Year in 120 Countries Medical Daily 01:39 Wed, 04 Nov

Monday

Gilead Tenofovir Cases: California Supreme Court Rejects Duty to Innovate or Accelerate Development of Alternatives to... JD Supra 18:20 Mon, 02 Nov

Gilead (GILD) Stock May Trade At A 47% Discount Following Raised Guidance Simply Wall St 16:53 Mon, 02 Nov

US approves cheap generic version of breakthrough HIV prevention jab The Independent 16:08 Mon, 02 Nov

FDA approves long-acting preventive drug for HIV Voice Of Emirates 14:43 Mon, 02 Nov

Gilead to Present Late-Breaking Clinical Data and Real-World Evidence at HIV Glasgow Business Wire (Press Release) 13:30 Mon, 02 Nov

Advertisement

In the last month

1 Dividend-Paying Biotech Stock to Buy Hand Over Fist in November The Motley Fool 21:12 Sun, 01 Nov

Who supplied US firm's remdesivir for Nipah treatment in Kerala? Kmscl to probe Malayala Manorama 01:19 Sat, 31 Oct

Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor Conferences Business Wire (Press Release) 20:05 Fri, 30 Oct

Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates Zacks 22:45 Thu, 29 Oct

Texas Reaches $45M Settlement With Gilead to Resolve Medicaid Kickback Allegations Over Patient-Support Programs JD Supra 19:26 Wed, 28 Oct

Gilead Successfully Completes Negotiations With Pan-Canadian Pharmaceutical Alliance For Lyvdelzi RTT News 12:50 Tue, 27 Oct

Study: Legal departments 'flooded' with AI correspondence RTE 06:03 Tue, 27 Oct

Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy? The Motley Fool 08:52 Sun, 25 Oct

The Lanier Law Firm Supports Attorney General Ken Paxton in Reaching $45 Million Settlement with Gilead in Unlawful Inducement Scheme Business Wire (Press Release) 18:28 Fri, 23 Oct

Gilead spends $1.28bn on PepStar’s potential Icotyde rival Pharmaceutical Technology 12:17 Fri, 23 Oct

Gilead to pay $45 million to settle kickback charges filed by Texas attorney general STAT 08:50 Fri, 23 Oct

Gilead Reaches $45M Settlement To End Kickback Claims Law360 01:38 Fri, 23 Oct

Gilead Will Pay $45 Million to End Texas Medicaid Kickback Suit Bloomberg Law 22:03 Thu, 22 Oct

Gilead to Acquire Investigational Oral Il-23R Inhibitor Hcxt-2001, Strengthening Its Inflammation Pipeline in IBD Business Wire (Press Release) 21:06 Thu, 22 Oct

Attorney General Ken Paxton Secures $45 Million Settlement with Big Pharma Company Gilead to Protect Texas Medicaid Texas Attorney General (Press Release) 20:02 Thu, 22 Oct

Gilead to Present New Data on Treatment Response and Long-Term Management of Rare Liver Diseases at The Liver Meeting® 2026 Business Wire (Press Release) 13:05 Thu, 22 Oct

BioNTech Expands Phase 3 Breast Cancer Trial Through Collaboration With Gilead RTT News 12:32 Thu, 22 Oct

Czech Foreign Ministry honours 13 laureates with Gratias Agit awards Radio Prague 11:17 Thu, 22 Oct

Gilead Sciences (GILD) Stock Drops Despite Market Gains: Important Facts to Note Zacks 00:05 Thu, 22 Oct

Gilead's Experimental Ulcerative Colitis Pill Beat Placebo by 23 Points on Remission, but Long-Term Safety Data Are Pending Medical Daily 10:46 Wed, 21 Oct

Korea approves Gilead's Livdelzi for primary biliary cholangitis Korea Biomedical Review 05:58 Wed, 21 Oct

Gilead’s IBS drug eliminated symptoms for patients, mid-stage study finds STAT 09:44 Mon, 19 Oct

Gilead Sciences Is on an FDA Approval Hot Streak. Should You Buy the Stock Like There's No Tomorrow? The Motley Fool 18:07 Sun, 18 Oct

Gilead and Vir forge $1.9bn pact to develop next-gen T-cell engagers Pharmaceutical Technology 03:36 Fri, 16 Oct

Gilead Sciences (GILD) Rises Higher Than Market: Key Facts Zacks 00:06 Fri, 16 Oct

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna